General Announcement::ASX:TLX; Nasdaq:TLX: ProstACT Global Phase 3 (Part 1) Achieves Primary Objectives

Issuer & Securities

Issuer/ Manager
TELIX PHARMACEUTICALS LIMITED
Securities
TELIXPHAR A$650M2.375%N290730 - XS2862961492 - JWQB
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
10-Mar-2026 05:52:38
Status
New
Announcement Sub Title
ASX:TLX; Nasdaq:TLX: ProstACT Global Phase 3 (Part 1) Achieves Primary Objectives
Announcement Reference
SG260310OTHR5VNY
Submitted By (Co./ Ind. Name)
Genevieve Ryan
Designation
Company Secretary
Effective Date and Time of the event
10/03/2026 10:30:00
Description (Please provide a detailed description of the event in the box below)
ASX:TLX; Nasdaq:TLX: ProstACT Global Phase 3 (Part 1) Achieves Primary Objectives

Attachments

20260310 ProstACT Global Part 1 Data Release vFINAL.pdf
Total size =216K